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a b s t r a c t
Pulmonary arteriovenous malformations (AVM) are very rare and carry the risk of cerebral
thrombo-embolism, brain abscess or pulmonary hemorrhage. The Amplatzer vascular plug
II (AVP II) is a new device, used for embolization of the pulmonary AVMs.We report a case of
pulmonary AVM successfully managed by using AVP II in a patient with hereditary hemor-
rhagic telangiectasia (HHT).
# 2015 Published by Elsevier B.V. on behalf of Cardiological Society of India.11. IntroductionPulmonary arteriovenous malformations are abnormal
direct communications between pulmonary arteries and
pulmonary veins which can be congenital or acquired. Due
to high success and low complication rate, trans-catheter* Corresponding author at: Department of Cardiology, Government Me
E-mail address: drrajeshgnair@gmail.com (G.N. Rajesh).
http://dx.doi.org/10.1016/j.ihj.2015.05.024
0019-4832/# 2015 Published by Elsevier B.V. on behalf of Cardiologicaclosure is the preferred treatment for such malformations.
A variety of devices like detachable occlusion balloon, coil
embolisation and Amplatzer vascular plugs are used for
embolotherapy of relatively large pulmonary AVMs. We
report a case of large pulmonary AVM from left pulmonary
artery (LPA) which was successfully treated with Amplatzer
Vascular Plug.dical College, Kozhikode, Kerala, India.
l Society of India.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 4 5 5 – 4 5 84562. Case reportA 20-year old male presented with 5 years history of
progressive effort dyspnea. He also had recurrent epistaxis
and bleeding per rectum. There was no family history of
bleeding disorders. Clinical examination showed central
cyanosis, pan-digital clubbing, normal heart sounds and no
murmur over the precordium. There was a short systolic
murmur audible in the left infra axillary area increasing with
deep inspiration and Muller's maneuver. Chest skiagram
showed a homogenous opacity in the left lower zone (Fig. 1A).
Electrocardiogram was normal. Trans-thoracic echocardio-
gram showed normal biventricular function and no obvious
intracardiac structural anomalies. There was an echolucent
area postero-lateral to the left ventricle (Fig. 1B). Contrast
echo with agitated saline showed ﬁlling of this echolucent
space followed by dense opaciﬁcation of left sided chambers,
a few cardiac cycles after appearance of contrast in the right
heart chambers (Fig. 1C, D, E). Computerized tomography (CT)
of thorax showed anAVM close to the left ventricle (Fig. 1F). In
retrospect, oxygen saturation in lying down position was 90%
with worsening of desaturation on standing up (82%)
suggestive of platypnoea ortho-deoxia syndrome. In view
of pulmonary AVM and recurrent epistaxis, hereditary[(Fig._1)TD$FIG]
Fig. 1 – (A) X-ray chest showing homogenous opacity in right low
view showing the echolucent space (AVM) posterior to left ventr
PLAX view filling the right ventricle and the AVM before reachin
apical four chamber view shows filling of the AVM situated later
contrast echocardiogram with agitated saline. (F) Contrast enhanhemorrhagic telangiectasia (HHT) was suspected. Further
evaluationwith CT scan brain and abdomen didn't reveal any
AVMs, aneurysm or infarcts. Nasal endoscopy showed
multiple arteriovenous malformations of nasal mucosa
(Fig. 2A). Upper gastro-intestinal endoscopy and colonoscopy
didn't demonstrate any telangiectasia. Pulmonary angiogram
showed large AVM arising from descending branch of left
pulmonary artery (Fig. 2B, C, D). No signiﬁcant feeders
(>3 mm)whichmaynecessitate coil embolisationafter device
closure of main vessel were identiﬁed. Angiographic studies
of celiac axis, superior and inferior mesenteric arteries were
normal. The patient fulﬁlled the Curacao criteria for heredi-
tary hemorrhagic telangiectasia (HHT) ashehad spontaneous
recurrent epistaxis, multiple telangiectasias in oral mucosa
and proven visceral AVM of lung.2
As the patient was not keen for surgery, device closure
with AVP II was planned. A 6-Fr Goodale-lubin (G L) catheter
was advanced into left pulmonary artery (LPA) and 0.03500
Backup Meier wire introduced through GL catheter into the
AVM. A 9-Fr ASD sheath was subsequently advanced over
the wire into lower branch of LPA. A 22 mm AVP II was
introduced through the sheath and deployed in the lower
division of LPA. Repeat angiogram didn't show ﬁlling of the
AVM and SpO2 improved to 98%. The patient is asymptom-
atic on follow up.er zone. (B) Trans-thoracic echo: parasternal long axis (PLAX)
icle. (C) Contrast echocardiogram using agitated saline in
g the left sided chambers. (D) Contrast echocardiogram in
al to left ventricle. (E) Dense filling of entire left heart during
ced CT-thorax showing pulmonary AVM.
[(Fig._2)TD$FIG]
Fig. 2 – (A) Nasal endoscopy showing the AVM in nasal mucosa. (B) Pulmonary angiogram showing the large AVM involving
descending branch of LPA. (C) Closure of AVM using Amplatzer vascular plug II. (D) Amplatzer vascular plug II in descending
branch of LPA.
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) 4 5 5 – 4 5 8 4573. DiscussionMore than 70% of pulmonary arteriovenous malformations
occur in patients with Osler–Weber-Rendu syndrome also
known as hereditary hemorrhagic telangiectasia.3 The syn-
drome is characterized by mucocutaneous telangiectasias
along with pulmonary, cerebral, and hepatic arteriovenous
malformations. Incidence of AVM in the lung ranges from 15%
to 33%.4 Dyspnea is the most common symptom and clinical
presentation depends on the number and size of the arterio-
venous ﬁstulas. Right-to left shunt due to AVM is usually well
tolerated. The most serious complications are paradoxical
embolismand cerebral abscess due to unobstructed passage of
bacteria and thrombi through the AVM. Because of the high
ﬂow and often large vessel diameter of pulmonary AVM, a
variety of devices and techniques have been described for
embolization. The AVP II is a new cylindrical self-expanding
device, made of nitinol wire mesh, used for arterio-venous
embolization in the peripheral vasculature. The advantages ofvascular plugs include easy release, reduced risk of migration
and complete occlusion with a single plug.
4. ConclusionLarge pulmonary AVM seen lucidly by transthoracic echocar-
diogram as an echolucent space postero-lateral to the left
ventricle, is seldom reported in the literature. Simple
investigation like contrast echocardiogram using agitated
saline can be used to conclusively identify pulmonary AVMs.
When treating pulmonary AVMs, embolization with AVP is a
less time consuming and safe method.5–7
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.ihj.2015.05.024.
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